Quinapril

This classification denotes an ace inhibitor with the molecular formula C25H30N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RJ84Y44811, chemically known as 3-isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3s-(2(r*(r*)),3r*))- but generally known as quinapril, which bears US NIH Compound Identifier 54892. European Medicines Agency schedules Quinapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10201MIG. The term QUINAPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules quinapril in its Anatomical Therapeutic Chemical (ATC) Classification. QUINAPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quinapril under HS 29334990 and SITC 51575. As of Q4 2014, QUINAPRIL remains the US FDA Preferred Term for this commodity. Quinapril bears US NLM identifiers UMLS ID C0072857 and NCI Concept Code C62074. SMILES: O=C(N1C(Cc2c(C1)cccc2)C(=O)O)C(NC(CCc1ccccc1)C(=O)OCC)C.